Transcriptional expression of 8 genes predicts pathological response to first-line docetaxel + trastuzumab-based neoadjuvant chemotherapy

BACKGROUND: Overexpression of HER2 is observed in 20 to 30% of breast carcinomas. The use of trastuzumab has improved the treatment of these patients, especially when it is associated with docetaxel. To optimize the use of this treatment, it seems important to select putative complete responders bef...

Full description

Saved in:
Bibliographic Details
Published in:BMC Cancer
Main Authors: Schmitt, Esther, Végran, Frédérique, Chevrier, Sandy, Burillier, Laura, Cadouot, Muriel, Lizard-Nacol, Sarab, Coudert, Bruno, Fumoleau, Pierre, Arnould, Laurent, Boidot, Romain
Format: Artigo
Language:Inglês
Published: BioMed Central 2015
Subjects:
Research Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4417290/
https://ncbi.nlm.nih.gov/pubmed/25879949
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-015-1198-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items